New Potomac Partners, LLC Amgen Inc Transaction History

New Potomac Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $104,944 - $124,969	-485 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $14,079 - $15,657	-60 Reduced 11.01%	485 $123,000
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $5,934 - $7,282	-30 Reduced 5.22%	545 $129,000
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $800,033 - $1.06 Million	-4,390 Reduced 88.42%	575 $117,000
Q4 2019 Jan 23, 2020	SELL	$189.21 - $243.2 $68,115 - $87,552	-360 Reduced 6.76%	4,965 $1.2 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $24,375 - $29,206	-140 Reduced 2.56%	5,325 $1.03 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $53,344 - $62,531	-320 Reduced 5.53%	5,465 $1.01 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $51,547 - $58,105	-285 Reduced 4.7%	5,785 $1.1 Million
Q4 2018 Jan 23, 2019	BUY	$178.4 - $208.25 $10,704 - $12,495	60 Added 1.0%	6,070 $1.18 Million
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $13,711 - $15,457	74 Added 1.25%	6,010 $1.25 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $2,490 - $2,797	-15 Reduced 0.25%	5,936 $1.1 Million
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $11,012 - $12,870	65 Added 1.1%	5,951 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $993,497 - $1.11 Million	5,886	5,886 $1.02 Million

3,056

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of New Potomac Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on New Potomac Partners, LLC with notifications on news.